MBX Biosciences, Inc. (MBX) stock
MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$53.10−0.02 (-0.04%)
Close on Nov 17, 2026Market cap $2.56BP/E –Yield –
MBX Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
MBX Biosciences's price to book ratio was 6.8× on Nov 11, 2026, against 4.0× a year earlier. Over the last 2 years it ranged from 1.0× to 7.2×, with a median of 3.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.8× | +3.1 |
| 2025 | Dec 31, 2025 | 3.6× | +1.4 |
| 2024 | Dec 31, 2024 | 2.3× | – |
See a number that looks wrong?